Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas

RAUL MIGUEL LUQUE HUERTASMANUEL DAVID GAHETE ORTIZALEJANDRO IBÁÑEZ COSTAJUSTO PASTOR CASTAÑO FUENTES2026-01-292026-01-29201510.1016/j.canlet.2015.01.0372-s2.0-84922970163https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/25881Cancer ResearchOncologyTruncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomasresearch article